logo

For the Inventor, By the Inventor

Erlensee, Germany

Gunther Wess

This inventor holds 26 USPTO granted patents, primarily in Bile Acid Derivatives. Top assignee: Hoechst Aktiengesellschaft. Active years: 1986-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunther Wess. Retrieved from https://idiyas.com/inventor/gunther-wess

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 14

Forward Citations = 358(Granted Patents)


Company Filing History:

goldMedal26 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1986-1997

Loading Chart...
Areas of Expertise:
Bile Acid Derivatives
Lipid-Selective Antioxidants
Proline Hydroxylase Inhibitors
Tetrazole Derivatives
3-Demethylmevalonic Acid
Thromboxane Synthetase Inhibitors
Optically Active Compounds
Imidazolyl Compounds
Pharmaceutical Compositions
Hydroxytetrahydropyran-2-Ones
Leukotriene Antagonists
3-Pyridyl Compounds
26 patents (USPTO):Explore Patents
1. 5668126 - Bile acid derivatives, processes for their preparation, and use as (1997-09-16),
2. 5646272 - Bile acid conjugates of proline hydroxylase inhibitors (1997-07-08),
3. 5641767 - Modified bile acids process for their preparation and their use (1997-06-24),
4. 5512558 - Nor-bile acid derivatives, processes for their preparation and the use (1996-04-30),
5. 5508275 - Lipid-selective antioxidants and their preparation and use (1996-04-16),
6. 5486626 - Process for the preparation of 3.beta.-aminocholanic acid derivatives (1996-01-23),
7. 5466815 - Tetrazole derivatives of bile acids, and their use as lipid level (1995-11-14),
8. 5462933 - Modified bile acid conjugates, and their use as pharmaceuticals (1995-10-31),
9. 5428182 - Bile acid derivatives, process for their preparation and use of these (1995-06-27),
10. 5318987 - Lipid-selective antioxidants and their preparation and use (1994-06-07),
11. 5294724 - 4-hydroxytetrahydropyran-2-ones and the corresponding (1994-03-15),
12. 5250524 - Bile acid derivatives, process for their preparation and use of these (1993-10-05),
13. 5204351 - 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof (1993-04-20),
14. 5166171 - 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and (1992-11-24),
15. 5091386 - 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acids and (1992-02-25),

Title: The Innovative Contributions of Gunther Wess

Introduction: Gunther Wess, a prominent inventor based in Erlensee, Germany, has made significant strides in the field of chemical innovations. With a remarkable portfolio of 26 patents, Wess has established himself as a key figure in the development of bile acid derivatives and their applications.

Latest Patents: Gunther Wess's latest patents include groundbreaking work on bile acid derivatives and processes for their preparation. These patents explore the use of bile acid derivatives of the formula I and bile acid conjugates of proline hydroxylase inhibitors, showcasing his commitment to advancing medicinal chemistry.

Career Highlights: Throughout his career, Gunther Wess has been associated with Hoechst Aktiengesellschaft, a leading pharmaceutical company known for its innovative research and development. His work has not only contributed to the company's success but has also impacted the broader scientific community.

Collaborations: Collaborating with notable colleagues such as Gerhard Beck and Wilhelm Bartmann, Wess has leveraged teamwork to enhance the impact of his research and inventions. These collaborations have resulted in advancements in the understanding and application of bile acid derivatives.

Conclusion: Gunther Wess's contributions to the field of chemical innovations, particularly through his patents and collaborative efforts, mark him as an influential inventor. His work continues to inspire ongoing research and development in the industry, making a lasting impact on scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…